Modernatx, Inc.
Clinical trials sponsored by Modernatx, Inc., explained in plain language.
-
New mRNA vaccines aim to outsmart evolving COVID variants
⭐️ VACCINE ⭐️ Recruiting nowThis study tests updated mRNA COVID-19 vaccines designed to target new virus variants. About 1,144 people will receive the vaccine to see how well it boosts immunity and if it is safe. The goal is to keep protection strong as the virus changes.
Phase: PHASE4 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 26, 2026 20:02 UTC
-
New COVID-19 vaccine trial aims to outsmart evolving variants
⭐️ VACCINE ⭐️ Recruiting nowThis study tests updated versions of the mRNA-1283 COVID-19 vaccine (mNEXSPIKE®) to see how well they protect against current virus variants. About 832 adults, especially those 65+ or with risk factors, will receive the vaccine. Researchers will measure immune response and monito…
Phase: PHASE4 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 26, 2026 20:00 UTC
-
New mRNA treatment for rare metabolic disease moves to Long-Term safety check
Disease control Recruiting nowThis study looks at the long-term safety of an experimental mRNA medicine called mRNA-3705 for people with methylmalonic acidemia (MMA), a rare genetic disorder. Participants have already taken part in earlier studies of this drug. The goal is to see if the treatment remains safe…
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
New study tracks health crises in rare metabolic disorder
Knowledge-focused Recruiting nowThis study is for people with propionic acidemia, a rare genetic condition that affects how the body breaks down certain proteins and fats. Researchers will look at medical records from about 60 participants to count how often serious metabolic events, hospital stays, and urgent …
Sponsor: ModernaTX, Inc. • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:02 UTC